We developed a drug discovery technology from the most diverse chemical library on earth – soil, focusing on bacteria as drug producers. Our POC, discovering pan-KRAS inhibitors, is aiming to be best-in-class with unique differentiating factors and is just the beginning — it unlocks a pipeline of drug-like natural molecules against some of the toughest targets in medicine, including undruggable targets that are major drivers of cancer, inflammatory diseases and more.